InfuSystem Holdings Inc
NYSE-MKT:INFU
Intrinsic Value
InfuSystem Holdings, Inc. engages in the provision of healthcare services. [ Read More ]
The intrinsic value of one INFU stock under the Base Case scenario is 10.88 USD. Compared to the current market price of 6.83 USD, InfuSystem Holdings Inc is Undervalued by 37%.
Valuation Backtest
InfuSystem Holdings Inc
Run backtest to discover the historical profit from buying and selling INFU stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
InfuSystem Holdings Inc
Current Assets | 32.5m |
Cash & Short-Term Investments | 822k |
Receivables | 20.5m |
Other Current Assets | 11.1m |
Non-Current Assets | 72.4m |
PP&E | 48.9m |
Intangibles | 10.9m |
Other Non-Current Assets | 12.5m |
Current Liabilities | 17.3m |
Accounts Payable | 9.8m |
Other Current Liabilities | 7.5m |
Non-Current Liabilities | 35.3m |
Long-Term Debt | 29.9m |
Other Non-Current Liabilities | 5.3m |
Earnings Waterfall
InfuSystem Holdings Inc
Revenue
|
127.4m
USD
|
Cost of Revenue
|
-63.4m
USD
|
Gross Profit
|
64m
USD
|
Operating Expenses
|
-60.7m
USD
|
Operating Income
|
3.4m
USD
|
Other Expenses
|
-3.3m
USD
|
Net Income
|
84k
USD
|
Free Cash Flow Analysis
InfuSystem Holdings Inc
INFU Profitability Score
Profitability Due Diligence
InfuSystem Holdings Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
InfuSystem Holdings Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
INFU Solvency Score
Solvency Due Diligence
InfuSystem Holdings Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
InfuSystem Holdings Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INFU Price Targets Summary
InfuSystem Holdings Inc
According to Wall Street analysts, the average 1-year price target for INFU is 15.13 USD with a low forecast of 12.63 USD and a high forecast of 17.85 USD.
Ownership
INFU Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
INFU Price
InfuSystem Holdings Inc
Average Annual Return | 35.88% |
Standard Deviation of Annual Returns | 77.86% |
Max Drawdown | -72% |
Market Capitalization | 145.4m USD |
Shares Outstanding | 21 264 700 |
Percentage of Shares Shorted | 0.93% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 420 full-time employees. The company went IPO on 2006-06-15. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.
Contact
IPO
Employees
Officers
The intrinsic value of one INFU stock under the Base Case scenario is 10.88 USD.
Compared to the current market price of 6.83 USD, InfuSystem Holdings Inc is Undervalued by 37%.